** Shares of Immuron IMC.AX rise 11.7% to A$0.067
** Stock set for its strongest session since January 14, if current trend holds
** The biopharmaceutical co says it has exceeded full-year sales of A$5 million ($3.08 million) for its Travelan drug, marking the co's highest annual sales
** About 437,320 shares change hands, 4.2x the 30-day average of 103,595 shares
** Stock down 15.2% YTD, including current session's moves
($1 = 1.6215 Australian dollars)
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.